JHEP Reports

Additional Metrics

Top Publications

• Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

  Tobias Boettler;Philip N. Newsome;Philip N. Newsome;Mario U. Mondelli;Mojca Maticic

  (2020)
  495 Citations

• Non-alcoholic fatty liver disease: A patient guideline.

  Sven M. Francque;Giulio Marchesini;Achim Kautz;Martine Walmsley

  (2021)
  196 Citations

• NAFLD and liver transplantation: Disease burden, current management and future challenges

  Patrizia Burra;Chiara Becchetti;Chiara Becchetti;Giacomo Germani

  (2020)
  163 Citations

• Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

  Tobias Boettler;Thomas Marjot;Philip N. Newsome;Philip N. Newsome;Mario U. Mondelli

  (2020)
  159 Citations

• Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.

  Zobair M. Younossi;Linda Henry

  (2021)
  150 Citations

• Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment

  Giacomo Zaccherini;Emmanuel Weiss;Emmanuel Weiss;Richard Moreau

  (2021)
  132 Citations

• Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.

  Eleonora De Martin;Jean-Marie Michot;Olivier Rosmorduc;Olivier Rosmorduc;Catherine Guettier

  (2020)
  127 Citations

• Understanding the cellular interactome of non-alcoholic fatty liver disease

  (2022)
  116 Citations

• Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction

  (2022)
  104 Citations

• Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort

  (2022)
  104 Citations